119 related articles for article (PubMed ID: 36605094)
1. A Network Perspective on Neuropsychiatric and Cognitive Symptoms of the Post-COVID Syndrome.
Scharfenberg D; Schild AK; Warnke C; Maier F
Eur J Psychol; 2022 Nov; 18(4):350-356. PubMed ID: 36605094
[TBL] [Abstract][Full Text] [Related]
2. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
[TBL] [Abstract][Full Text] [Related]
4. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms.
Delgado-Alonso C; Díez-Cirarda M; Pagán J; Pérez-Izquierdo C; Oliver-Mas S; Fernández-Romero L; Martínez-Petit Á; Valles-Salgado M; Gil-Moreno MJ; Yus M; Matías-Guiu J; Ayala JL; Matias-Guiu JA
Eur J Neurol; 2023 Oct; ():. PubMed ID: 37797297
[TBL] [Abstract][Full Text] [Related]
5. Herbal Medicines for Post-Acute Sequelae (Fatigue or Cognitive Dysfunction) of SARS-CoV-2 Infection: A Phase 2 Pilot Clinical Study Protocol.
Jegal KH; Yoon J; Kim S; Jang S; Jin YH; Lee JH; Choi SM; Kim TH; Kwon S
Healthcare (Basel); 2022 Sep; 10(10):. PubMed ID: 36292286
[TBL] [Abstract][Full Text] [Related]
6. Neurological Sequelae of COVID-19.
Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
[TBL] [Abstract][Full Text] [Related]
7. A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms.
Guest PC; Neyazi A; Braun-Dullaeus RC; Müller P; Schreiber J; Haghikia A; Vasilevska V; Steiner J
Adv Exp Med Biol; 2023; 1412():97-115. PubMed ID: 37378763
[TBL] [Abstract][Full Text] [Related]
8. Chronic fatigue syndrome and cognitive deficit are associated with acute-phase neuropsychiatric manifestations of COVID-19: A 9-month follow-up study.
Mirfazeli FS; Sarabi-Jamab A; Pereira-Sanchez V; Kordi A; Shariati B; Shariat SV; Bahrami S; Nohesara S; Almasi-Dooghaee M; Faiz SHR
Neurol Sci; 2022 Apr; 43(4):2231-2239. PubMed ID: 35059902
[TBL] [Abstract][Full Text] [Related]
9. The determinants of COVID-induced brain dysfunctions after SARS-CoV-2 infection in hospitalized patients.
Yasir S; Jin Y; Razzaq FA; Caballero-Moreno A; Galán-García L; Ren P; Valdes-Sosa M; Rodriguez-Labrada R; Bringas-Vega ML; Valdes-Sosa PA
Front Neurosci; 2023; 17():1249282. PubMed ID: 38260018
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring the development of post-COVID–19 syndrome].
Tamasi J; Kalabay L
Orv Hetil; 2022 Feb; 163(9):335-342. PubMed ID: 35220274
[TBL] [Abstract][Full Text] [Related]
11. Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Taquet M; Skorniewska Z; Zetterberg H; Geddes JR; Mummery CJ; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Houchen-Wolloff L; Mansoori P; Greening NJ; Harrison EM; Docherty AB; Lone NI; Quint J; Greenhalf W; Wain LV; Brightling CE; Evans RE; Harrison PJ; Koychev I;
Brain Commun; 2024; 6(1):fcad357. PubMed ID: 38229877
[TBL] [Abstract][Full Text] [Related]
12. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
[TBL] [Abstract][Full Text] [Related]
13. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Azcue N; Gómez-Esteban JC; Acera M; Tijero B; Fernandez T; Ayo-Mentxakatorre N; Pérez-Concha T; Murueta-Goyena A; Lafuente JV; Prada Á; López de Munain A; Ruiz-Irastorza G; Ribacoba L; Gabilondo I; Del Pino R
J Transl Med; 2022 Dec; 20(1):569. PubMed ID: 36474290
[TBL] [Abstract][Full Text] [Related]
14. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of Post-COVID syndromes: a new perspective.
Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Welson NN
Virol J; 2022 Oct; 19(1):158. PubMed ID: 36210445
[TBL] [Abstract][Full Text] [Related]
16. COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study.
Guo P; Benito Ballesteros A; Yeung SP; Liu R; Saha A; Curtis L; Kaser M; Haggard MP; Cheke LG
Front Aging Neurosci; 2022; 14():804937. PubMed ID: 35370620
[TBL] [Abstract][Full Text] [Related]
17. Structural brain changes in patients with post-COVID fatigue: a prospective observational study.
Heine J; Schwichtenberg K; Hartung TJ; Rekers S; Chien C; Boesl F; Rust R; Hohenfeld C; Bungenberg J; Costa AS; Scheibenbogen C; Bellmann-Strobl J; Paul F; Franke C; Reetz K; Finke C
EClinicalMedicine; 2023 Apr; 58():101874. PubMed ID: 36873426
[TBL] [Abstract][Full Text] [Related]
18. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
Carod-Artal FJ
Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
[TBL] [Abstract][Full Text] [Related]
19. Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case report.
Jozuka R; Kimura H; Uematsu T; Fujigaki H; Yamamoto Y; Kobayashi M; Kawabata K; Koike H; Inada T; Saito K; Katsuno M; Ozaki N
Neuropsychopharmacol Rep; 2022 Mar; 42(1):114-119. PubMed ID: 34889531
[TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
